| Hca Houston Healthcare Tomball | |
| 605 Holderrieth, Tomball, Texas 77375 | |
| (281) 351-1623 | |
| Name | Hca Houston Healthcare Tomball |
|---|---|
| Type | Acute Care Hospital |
| Location | 605 Holderrieth, Tomball, Texas |
| Ownership | Proprietary |
| Emergency Services | Yes |
| Medicare ID (CCN) | 450670 |
| NPI Number | 1194026534 |
| Organization Name | TOMBALL REGIONAL HOSPITAL |
| Address | 605 Holderrieth Blvd, Tomball, TX 77375 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 281-401-7500 |
News Archive
Kaiser Foundation Hospitals, Kaiser Foundation Health Plan, Inc., and their respective subsidiaries reported today a combined total operating revenue of $11.0 billion for the quarter ended June 30, 2010, compared to $10.5 billion in the same period in 2009. Operating income was $313 million in the second quarter of 2010, compared to $411 million in the same quarter last year.
European researchers are working on a novel hybrid device to better understand the metastatic process of cancer cells travelling from breast to bone and fast screen new drugs against it.
Talk to anyone for very long about how to improve health care in the U.S. and you eventually hear something along the lines of: "We have to start paying physicians for getting and keeping people healthy instead of for doing as many procedures and tests as possible" (Hobson, 6/9).
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
› Verified 2 days ago
| NPI Number | 1306126974 |
| Organization Name | TOMBALL TEXAS HOSPITAL COMPANY LLC |
| Doing Business As | TOMBALL REGIONAL MEDICAL CENTER |
| Address | 605 Holderrieth Blvd, Tomball, TX 77375 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 281-401-7500 |
News Archive
Kaiser Foundation Hospitals, Kaiser Foundation Health Plan, Inc., and their respective subsidiaries reported today a combined total operating revenue of $11.0 billion for the quarter ended June 30, 2010, compared to $10.5 billion in the same period in 2009. Operating income was $313 million in the second quarter of 2010, compared to $411 million in the same quarter last year.
European researchers are working on a novel hybrid device to better understand the metastatic process of cancer cells travelling from breast to bone and fast screen new drugs against it.
Talk to anyone for very long about how to improve health care in the U.S. and you eventually hear something along the lines of: "We have to start paying physicians for getting and keeping people healthy instead of for doing as many procedures and tests as possible" (Hobson, 6/9).
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
› Verified 2 days ago
| NPI Number | 1750415808 |
| Organization Name | TOMBALL HOSPITAL AUTHORITY |
| Doing Business As | TOMBALL REGIONAL HOSPITAL SECTION 1101 UNDOC ALIENS |
| Address | 605 Holderrieth, Tomball, TX 77375 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 281-401-7500 |
News Archive
Kaiser Foundation Hospitals, Kaiser Foundation Health Plan, Inc., and their respective subsidiaries reported today a combined total operating revenue of $11.0 billion for the quarter ended June 30, 2010, compared to $10.5 billion in the same period in 2009. Operating income was $313 million in the second quarter of 2010, compared to $411 million in the same quarter last year.
European researchers are working on a novel hybrid device to better understand the metastatic process of cancer cells travelling from breast to bone and fast screen new drugs against it.
Talk to anyone for very long about how to improve health care in the U.S. and you eventually hear something along the lines of: "We have to start paying physicians for getting and keeping people healthy instead of for doing as many procedures and tests as possible" (Hobson, 6/9).
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
› Verified 2 days ago
| NPI Number | 1750819025 |
| Organization Name | NORTH HOUSTON - TRMC, LLC |
| Doing Business As | HCA HOUSTON HEALTHCARE TOMBALL |
| Address | 605 Holderrieth Blvd, Tomball, TX 77375 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 281-401-7500 |
News Archive
Kaiser Foundation Hospitals, Kaiser Foundation Health Plan, Inc., and their respective subsidiaries reported today a combined total operating revenue of $11.0 billion for the quarter ended June 30, 2010, compared to $10.5 billion in the same period in 2009. Operating income was $313 million in the second quarter of 2010, compared to $411 million in the same quarter last year.
European researchers are working on a novel hybrid device to better understand the metastatic process of cancer cells travelling from breast to bone and fast screen new drugs against it.
Talk to anyone for very long about how to improve health care in the U.S. and you eventually hear something along the lines of: "We have to start paying physicians for getting and keeping people healthy instead of for doing as many procedures and tests as possible" (Hobson, 6/9).
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
› Verified 2 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Kaiser Foundation Hospitals, Kaiser Foundation Health Plan, Inc., and their respective subsidiaries reported today a combined total operating revenue of $11.0 billion for the quarter ended June 30, 2010, compared to $10.5 billion in the same period in 2009. Operating income was $313 million in the second quarter of 2010, compared to $411 million in the same quarter last year.
European researchers are working on a novel hybrid device to better understand the metastatic process of cancer cells travelling from breast to bone and fast screen new drugs against it.
Talk to anyone for very long about how to improve health care in the U.S. and you eventually hear something along the lines of: "We have to start paying physicians for getting and keeping people healthy instead of for doing as many procedures and tests as possible" (Hobson, 6/9).
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
› Verified 2 days ago
Hca Houston Healthcare Tomball Acute Care Hospital Location: 605 Holderrieth, Tomball, Texas 77375 Phone: (281) 351-1623 |